Ann Rowley

Ann Rowley is a self-motivated research scientist currently serving as the Director of Targeted Protein Degradation at Merck. With a PhD in Chemistry from the University of Pennsylvania, Ann has extensive experience in the pharmaceutical industry, having held positions at DuPont, Infinity Pharmaceuticals, AbbVie, GSK, and the Broad Institute. Ann has demonstrated skills in organic and medicinal chemistry, including multi-step synthesis and biological data-driven analog design. Known for collaborating across scientific disciplines, Ann has a strong record of publications and presentations, and consistently meets aggressive deadlines while leading teams in innovative research environments.